| Bioactivity | LY3202626 is a CNS penetrant BACE inhibitor with IC50s of 0.615 nM and 0.871 nM against BACE1 and BACE2, respectively[1]. |
| Target | IC50: 0.615 nM (BACE1), 0.871 nM (BACE2) |
| Name | LY3202626 |
| CAS | 1628690-73-2 |
| Formula | C22H20F2N8O2S |
| Molar Mass | 498.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. McKinzie DL, et al. Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor. J Med Chem. 2021 Jun 24;64(12):8076-8100. |
LY3202626
CAS: 1628690-73-2 F: C22H20F2N8O2S W: 498.51
LY3202626 is a CNS penetrant BACE inhibitor with IC50s of 0.615 nM and 0.871 nM against BACE1 and BACE2, respectively.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.